The first trial against two manufacturers of transvaginal mesh products has ended in a verdict for both companies.
The jury in the 16th Judicial Circuit Court in Jackson County, Missouri, which began hearing opening statements in the trial on Dec. 2, found that both Boston Scientific Corp. and C.R. Bard Inc. weren’t liable for plaintiff Eve Sherrer’s injuries. Sherrer’s case is one of 70,000 lawsuits filed against seven companies alleging their mesh devices, which are surgically implanted to treat urinary incontinence and pelvic organ prolapse, have caused pain and subsequent surgeries to remove them.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
